(Q42629242)

4 November 2017

title

An open-label pilot study of risperidone in the treatment of methamphetamine dependence (English)

1 reference

4 November 2017

1 reference

Charles W Meredith

1

1 reference

4 November 2017

Craig Jaffe

2

1 reference

4 November 2017

Elisia Yanasak

3

1 reference

4 November 2017

Monique Cherrier

4

1 reference

4 November 2017

Andrew J Saxon

5

1 reference

4 November 2017

publication date

1 June 2007

1 reference

Journal of Psychoactive Drugs

4 November 2017

published in

1 reference

4 November 2017

volume

39

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

167-172

1 reference

Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Word-list generation deficits in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

A controlled trial of imipramine for the treatment of methamphetamine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Imipramine for the treatment of cocaine and methamphetamine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

A pilot trial of olanzapine for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Corticotropin-releasing factor, norepinephrine, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Dopamine transport function is elevated in cocaine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

The Brief Symptom Inventory (BSI) as an outcome measure for adult psychiatric inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

The effect of relapse on cognition in abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

A comparison of patterns of methamphetamine and cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2007.10399875

10.1080/02791072.2007.10399875

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference